Sinopharm Group Co., Ltd. Stock Other OTC
Equities
SHTDY
US82937K1016
Pharmaceuticals
Sales 2024 * | 649B 89.81B 122B | Sales 2025 * | 707B 97.82B 133B | Capitalization | 63.41B 8.78B 11.95B |
---|---|---|---|---|---|
Net income 2024 * | 9.63B 1.33B 1.81B | Net income 2025 * | 10.59B 1.47B 2B | EV / Sales 2024 * | 0.12 x |
Net Debt 2024 * | 11.49B 1.59B 2.17B | Net Debt 2025 * | 9.36B 1.3B 1.76B | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
6.58
x | P/E ratio 2025 * |
5.98
x | Employees | - |
Yield 2024 * |
4.6% | Yield 2025 * |
5.05% | Free-Float | 42.99% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Liu
PSD | President | 55 | 09-01-08 |
Shuang Jun Xu
PRN | Corporate Officer/Principal | 55 | 11-02-28 |
Zhong Xi Cai
PRN | Corporate Officer/Principal | 59 | 10-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 10-04-30 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 19-01-10 |
Dong Jiu Li
BRD | Director/Board Member | 59 | 13-10-17 |
1st Jan change | Capi. | |
---|---|---|
+21.93% | 73.38B | |
-1.71% | 24.13B | |
+10.34% | 8.59B | |
-19.80% | 8.06B | |
+14.16% | 5.26B | |
-0.03% | 4.21B | |
+12.70% | 4.17B | |
-2.54% | 3.89B | |
+24.00% | 3.71B |